You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤
Overview
In The News
Executives & Employees
Board of Directors
Paths
Owners & Shareholders
Recent Transactions
Transaction Advisors
Advisors & Consultants
Clients
Financials
Suppliers
Competitors

RedHill Biopharma Ltd.

OVERVIEW

Headquarters
21 Ha'arba'a Street, Tel Aviv 64739
Type of Company
Public
Employees (Worldwide)
27
Industries
Pharmaceuticals

Retail: Drug Stores

Biotechnology
Company Description
RedHill Biopharma Ltd. is a biopharmaceutical company, which is focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. The company's gastrointestinal products include Donnatal and EnteraGam. Its clinical-stage pipeline includes TALICIA, RHB-104¸ BEKINDA, RHB-106, YELIVA, MESUPRON, and RIZAPORT. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Website

In The News See more

News Bites Canadian Markets
September 14, 2017
News Bites Canadian Markets
August 18, 2017
Marketline Newswire
July 31, 2017
Marketline Newswire
July 17, 2017
Marketline Newswire
July 12, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees


Chief Executive Officer

Chief Financial Officer

Medical Director

Medical Director, Oncology

Director-Clinical Operations

Vice President-Business Development & Communications

Vice President-Clinical Affairs, Europe

Vice President, Intellectual Property & Research

Vice President-Regulatory Affairs

Vice President, US Sales
See our list of current and previous employees when you upgrade.

Board of Directors


Chief Executive Officer at RedHill Biopharma Ltd.

Founder at CFO Forum

Former Chief Scientist at Ethrog Biotechnologies Ltd

Chief Financial Officer at TabTale Ltd.

Director at Minerva Biotechnologies Corp.

Former Chairman & Chief Executive Officer at Vandemoortele NV

Founder at DOORS Information Systems, Inc.

Director at Medasense Biometrics Ltd.

Executive Vice President, Business Development at Salix Pharmaceuticals, Inc.
See our list of current and previous board members when you upgrade.

Paths to RedHill Biopharma Ltd.

RedHill Biopharma Ltd.
You
Connections via Relationship Science
RedHill Biopharma Ltd.
Sync your contacts to see how you can connect with RedHill Biopharma Ltd..

Owners & Shareholders

Details Hidden
Peilim Portfolio Management Co Ltd., part of Bank Hapoalim BM, is a company headquartered in Tel Aviv, Israel. The firm provides Investment Advice. Rebecca Algrisi is currently the CEO of the company.
Details Hidden
Sabby Capital focuses on investments in the healthcare sector.
Details Hidden
Sabby Capital focuses on investments in the healthcare sector.
Details Hidden
Peilim Portfolio Management Co Ltd., part of Bank Hapoalim BM, is a company headquartered in Tel Aviv, Israel. The firm provides Investment Advice. Rebecca Algrisi is currently the CEO of the company.

Recent Transactions

Details Hidden
RedHill Biopharma Ltd. issued American Depositary Shares (ADS)
Details Hidden
RedHill Biopharma Ltd. issued American Depositary Shares
Details Hidden
RedHill Biopharma Ltd. issued American Depositary Shares
Details Hidden
RedHill Biopharma Ltd. raised money in a private placement transaction
Details Hidden
RedHill Biopharma Ltd. issued Units

Transaction Advisors

Companies ▾
Auditor
Advised on RedHill Biopharma Ltd. issued Units
Underwriter
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Legal Advisor
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Legal Advisor
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Manager
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
People ▾
Legal Advisor
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Associate
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Associate
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Managing Director
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
Managing Director
Advised on RedHill Biopharma Ltd. issued American Depositary Shares
See 6 more listings with RelSci Professional.

Advisors & Consultants

People ▾
Advisor

Senior Vice President at The Trout Group LLC
Advisor

Vice President & Managing Director at RedHill Biopharma Ltd.

Clients

Companies ▾
   Zug, ZG
Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International, The Branded Rx, and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Key Stats and Financials as of 2016

Market Capitalization
$540M
Total Enterprise Value
$266M
Earnings Per Share
$-0.88
Revenue
$388K
Net Profit
$-113M
EBITDA
$-117M
EBITDAMargin
-30.2K%
Total Debt
$0
Total Equity
$241M
Enterprise Value Sales
685.51x
TEVNet Income
-2.36x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
107.64%
Five Year Compounded Annual Growth Rate Of Revenue
36.49%
See financial details and more using RelSci Professional.

Suppliers

   Human Resources & Personnel Services    ORLANDO, FL
The University of Central Florida, commonly referred to as UCF, is a metropolitan public research university located in Orlando, Florida, United States. UCF is a member institution of the State University System of Florida, and it is the second-largest university in the United States by enrollment. The university was founded by the Florida Legislature in 1963, and opened in 1968 as Florida Technological University, with the mission of providing personnel to support the growing U.S. space program at the Kennedy Space Center and Cape Canaveral Air Force Station on Florida's Space Coast. As the academic scope expanded beyond its original focus on engineering and technology, "Florida Tech" was renamed The University of Central Florida in 1978. Initial enrollment was only 1,948 students, as of 2014 enrollment consists of 59,770 students from over 140 countries, all 50 states, Puerto Rico and Washington, D.C. The majority of the student population is located on the university's 1,415-acre (5.73 km2) main campus approximately 13 miles (21 km) east-northeast of downtown Orlando and 55 miles (89 km) south-southwest of Daytona Beach. The university offers over 200 degree options through twelve colleges and twelve satellite campuses throughout Central Florida. Since its founding, UCF has awarded almost 250,000 degrees, including 45,000 graduate, specialist and professional degrees, to over 230,000 alumni worldwide.
   Other Business & Consulting Services    Sydney, NS
Giaconda Ltd. engages in the development and commercialization of therapies for gastrointestinal diseases and disorders. The company was founded by Thomas Julius broody on February 23, 2004 and is headquartered in Sydney, Australia.
   Pharmaceuticals    Munich, BV
WILEX AG engages in the development of diagnostic and therapeutic products for the detection and targeted treatment of various types of cancer. It operates through the following segments: Customer Specific Research (Cx), Diagnostics (Dx) andTherapeutics (Rx). The Customer Specific Research segment includes preclinical and Antibody Drug Conjugate technology services. The Diagnostics segment handles the imaging diagnostic candidate REDECTANE. The Therapeutics segment comprises of the following programmes: MESUPRON, WX-554, WX-037 as well as all preclinical and research activities of WILEX AG. The company was founded by Olaf G. Wilhelm, Manfred Schmitt, Viktor Magdolen, Heinrich Graeff, Bernd Gänsbacher, Horst Kessler, Peter Nawroth and Thomas Luther in September 1997 and is headquartered in Munich, Germany.
   Pharmaceuticals    Ville Saint-Laurent, QC
IntelGenx Technologies Corp. operates as a drug delivery company. It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies. The company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. Its research and development pipeline includes products for the treatment of severe depression, hypertension, erectile dysfunction, benign prostatic hyperplasia, migraine, insomnia, bipolar disorder, idiopathic pulmonary fibrosis, allergies and pain management. IntelGenx Technologies was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.
       Montréal, QC
See 6 more listings with RelSci Professional.

Competitors

   Pharmaceuticals    Kenilworth, New Jersey
Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.
   Pharmaceuticals    Brentford, GL
‘GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
   Pharmaceuticals    Zug, ZG
Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International, The Branded Rx, and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.
   Pharmaceuticals    Dublin, DU
Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences. The CHC segment includes the company's former segments, which are the Nutritionals and Israel Pharmaceuticals and Diagnostics business. The BCH segment consists of the Omega business. The Prescription Pharmaceuticals includes the Rx Pharmaceuticals business. The Specialty Sciences segment comprises of the assets, which focuses on the treatment of multiple sclerosis. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
   Pharmaceuticals    Dublin, DU
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded on in 1984 and is headquartered in Dublin, Ireland.
See 10 more listings with RelSci Professional.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial ➤
Still not convinced? Check out our full listing of features here.